Skip to content

Susan Mahony, Director at Axsome Therapeutics, sold AXSM on Jun 10, 2026

Data as of Oct 16

▼ SELL$73.9K300 shares at $246.18Susan Mahony DirectorAXSM Axsome Therapeutics, Inc.
Watch AXSM
Traded
Jun 10, 2026
Disclosed
Jun 10, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Susan Mahony, Director at Axsome Therapeutics, sold AXSM on Jun 10, 2026TRADEDDISCLOSED
AXSMSimilar stocks (XLV — its sector index fund), rebased to AXSM's price on the disclosure day
AXSM since disclosure
−36.2%
after the sale
Similar stocks (XLV) since disclosure
+15.6%
XLV — its sector index fund

Change in closing price from Jun 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSusan Mahony DirectorAXSM Axsome Therapeutics, Inc.$71.2Kdisclosed Jun 10 · filed 1 day after the trade

See every trade on AXSM →